Foote RL - Search Results

1

The clinical case for proton beam therapy.

Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. Foote RL, et al. Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Radiat Oncol. 2012. PMID: 23083010 Free PMC article. Review.

2

Results of radiotherapy for chemodectomas.

Schild SE, Foote RL, Buskirk SJ, Robinow JS, Bock FF, Cupps RE, Earle JD. Schild SE, et al. Among authors: foote rl. Mayo Clin Proc. 1992 Jun;67(6):537-40. doi: 10.1016/s0025-6196(12)60460-1. Mayo Clin Proc. 1992. PMID: 1331629 Review.

3

Locally recurrent non-small-cell lung cancer after complete surgical resection.

Shaw EG, Brindle JS, Creagan ET, Foote RL, Trastek VF, Buskirk SJ. Shaw EG, et al. Among authors: foote rl. Mayo Clin Proc. 1992 Dec;67(12):1129-33. doi: 10.1016/s0025-6196(12)61141-0. Mayo Clin Proc. 1992. PMID: 1335100

4

Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy.

Foote RL, Olsen KD, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Foote RL, et al. Mayo Clin Proc. 1992 Jul;67(7):629-36. doi: 10.1016/s0025-6196(12)60716-2. Mayo Clin Proc. 1992. PMID: 1434895

5

Is interstitial implantation essential for successful radiotherapeutic treatment of base of tongue carcinoma?

Foote RL, Parsons JT, Mendenhall WM, Million RR, Cassisi NJ, Stringer SP. Foote RL, et al. Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1293-8. doi: 10.1016/0360-3016(90)90300-9. Int J Radiat Oncol Biol Phys. 1990. PMID: 2370179

6

External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis.

Foote RL, Garretson BR, Schomberg PJ, Buskirk SJ, Robertson DM, Earle JD. Foote RL, et al. Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):823-30. doi: 10.1016/0360-3016(89)90502-6. Int J Radiat Oncol Biol Phys. 1989. PMID: 2493436

7

Patterns of failure after total laryngectomy for glottic carcinoma.

Foote RL, Buskirk SJ, Stanley RJ, Grambsch PM, Olsen KD, DeSanto LW, Earle JD, Weiland LH. Foote RL, et al. Cancer. 1989 Jul 1;64(1):143-9. doi: 10.1002/1097-0142(19890701)64:1<143::aid-cncr2820640124>3.0.co;2-i. Cancer. 1989. PMID: 2731110

8

Alleviation of cytotoxic therapy-induced normal tissue damage.

Loprinzi CL, Foote RL, Michalak J. Loprinzi CL, et al. Among authors: foote rl. Semin Oncol. 1995 Apr;22(2 Suppl 3):95-7. Semin Oncol. 1995. PMID: 7740323 Review.

9

Laryngectomy alone for T3 glottic cancer.

Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Foote RL, et al. Head Neck. 1994 Sep-Oct;16(5):406-12. doi: 10.1002/hed.2880160503. Head Neck. 1994. PMID: 7960737

10

Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement.

Olsen KD, Caruso M, Foote RL, Stanley RJ, Lewis JE, Buskirk SJ, Frassica DA, DeSanto LW, O'Fallon WM, Hoverman VR. Olsen KD, et al. Among authors: foote rl. Arch Otolaryngol Head Neck Surg. 1994 Dec;120(12):1370-4. doi: 10.1001/archotol.1994.01880360066012. Arch Otolaryngol Head Neck Surg. 1994. PMID: 7980903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters